RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Clinical trials for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to wipe out stubborn leukemia cells
Disease control Recruiting nowThis study tests whether adding venetoclax to standard chemotherapy (CLAG-M) can better clear leukemia cells in people whose acute myeloid leukemia (AML) has returned or not responded to prior treatment. About 52 adults aged 18 to 80 will be randomly assigned to receive either th…
Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New hope for older leukemia patients: safer transplant prep may boost survival
Disease control Recruiting nowThis study tests a new combination of drugs (cladribine, lisaftolax, and busulfan) given before a stem cell transplant in people aged 50 and older with relapsed or hard-to-treat acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The goal is to make the transplant saf…
Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC